The Enteric Disease Testing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Reagents and Consumables, Equipment), By Technique (Molecular Diagnostics, Immunodiagnostics), By Disease Type (Bacterial Enteric Disease, Viral Enteric Disease, Parasitic Enteric Disease), By End-User (Academic and Research Institutes, Hospital Laboratories, Pharmaceutical and Biotechnology Companies).
The enteric disease testing market in 2025 addresses the demand for diagnostic tests and assays used to detect and identify infectious agents, pathogens, and biomarkers associated with enteric diseases and gastrointestinal infections, including bacterial, viral, and parasitic pathogens transmitted through contaminated food, water, and fecal-oral routes. Enteric disease testing encompasses a wide range of laboratory techniques such as culture-based methods, molecular diagnostics (PCR, qPCR), immunoassays, and rapid antigen tests, targeting pathogens such as Salmonella, Escherichia coli (E. coli), norovirus, and Clostridium difficile (C. diff), as well as inflammatory markers and fecal occult blood for the diagnosis and management of gastroenteritis, foodborne illnesses, and inflammatory bowel diseases (IBD). Market dynamics are driven by factors such as the increasing incidence of enteric infections, the growing demand for rapid and accurate diagnostic tests, and advancements in enteric disease surveillance, outbreak investigation, and public health interventions for improved disease control and prevention. Collaboration between enteric disease test manufacturers, clinical laboratories, and public health agencies drives innovation and market expansion in enteric disease testing, supporting early detection, treatment optimization, and infectious disease control strategies in gastroenterology and public health.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments across Abbott, Becton, Dickinson and Company, Biomerica, BIOMÉRIEUX, Bio-Rad Laboratories Inc, Cepheid, Coris BioConcept, DiaSorin S.p.A., Meridian Bioscience, Quest Diagnostics Inc
A significant trend in the Enteric Disease Testing market is the increasing adoption of rapid molecular diagnostics technologies for the detection and identification of enteric pathogens. Traditional methods for enteric disease testing, such as culture-based techniques, often require prolonged incubation periods and may lack sensitivity and specificity, leading to delays in diagnosis and treatment. In contrast, molecular diagnostic assays, including polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs), offer rapid and accurate detection of enteric pathogens, enabling healthcare providers to promptly diagnose infections, implement appropriate treatment strategies, and mitigate the spread of infectious diseases. As healthcare systems prioritize timely diagnosis and surveillance of enteric diseases, there is a growing demand for molecular diagnostic platforms that offer multiplexing capabilities, high throughput, and point-of-care testing options, driving market growth in this segment.
A key driver in the Enteric Disease Testing market is the rising incidence of foodborne and waterborne illnesses globally, necessitating effective diagnostic solutions to identify the causative agents and prevent outbreaks. Enteric diseases, such as salmonellosis, campylobacteriosis, and norovirus gastroenteritis, pose significant public health challenges, leading to substantial morbidity, mortality, and economic burden worldwide. With the globalization of food supply chains, changes in agricultural practices, and environmental factors, the risk of enteric infections remains prevalent, underscoring the importance of robust diagnostic capabilities for timely intervention and disease control. Healthcare providers, regulatory agencies, and food safety authorities are increasingly focusing on surveillance, outbreak investigation, and preventive measures, driving the demand for enteric disease testing solutions that offer rapid, reliable, and comprehensive pathogen detection capabilities to safeguard public health.
An opportunity for growth in the Enteric Disease Testing market lies in the development of multiplex molecular assays and point-of-care testing (POCT) platforms for decentralized testing and surveillance. Multiplex molecular assays capable of detecting multiple enteric pathogens simultaneously offer advantages in terms of efficiency, cost-effectiveness, and resource utilization, enabling healthcare providers to streamline testing workflows, conserve laboratory resources, and expedite diagnostic turnaround times. Additionally, there is a growing demand for POCT solutions that can be deployed in various healthcare settings, including clinics, emergency departments, and remote areas, to facilitate rapid diagnosis and decision-making at the point of care. By investing in research and development initiatives focused on developing multiplex molecular assays and portable POCT platforms, manufacturers can address unmet needs in enteric disease testing, expand market reach, and capitalize on the growing demand for decentralized diagnostic solutions in the evolving landscape of infectious disease management.
The molecular diagnostics segment is expected to lead the enteric disease testing market in 2025, primarily due to its unmatched accuracy, speed, and ability to detect multiple pathogens simultaneously. This technique is increasingly preferred in clinical settings for the rapid identification of bacterial, viral, and parasitic agents responsible for gastrointestinal infections, which is critical in preventing outbreaks and improving patient outcomes. The surge in antibiotic resistance and the demand for personalized treatment strategies are further encouraging the adoption of molecular methods over traditional techniques. Moreover, technological advancements such as multiplex PCR panels, point-of-care nucleic acid tests, and automated platforms are enhancing the efficiency and scalability of molecular diagnostics. Hospitals, diagnostic laboratories, and public health institutions are investing heavily in this technology, recognizing its role in enabling early detection, targeted therapy, and surveillance of enteric diseases. These advantages are expected to keep molecular diagnostics at the forefront of market growth, especially in high-burden regions where timely diagnosis is crucial for managing widespread infections and minimizing public health risks.
The Viral Enteric Disease segment is projected to be the fastest-growing in the enteric disease testing market during the forecast period to 2034. This growth is primarily driven by the increasing global incidence of viral gastroenteritis, especially norovirus and rotavirus infections, which are highly contagious and affect both developed and developing nations. Improved diagnostic technologies such as PCR and rapid antigen tests are making viral detection more efficient, supporting faster adoption in clinical settings. Moreover, climate change, global travel, and urban overcrowding are contributing to a higher transmission risk, further increasing the need for robust viral testing. Public health initiatives aimed at controlling outbreaks and expanding surveillance programs are also accelerating the demand for viral enteric disease diagnostics. As healthcare systems emphasize early detection and prevention of viral spread, this segment is poised for significant expansion.
By Product
By Technique
By Disease Type
By End-User
Geographical Analysis
*List not Exhaustive
TABLE OF CONTENTS
1 Introduction to 2025 Enteric Disease Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Enteric Disease Testing Market Size Outlook, $ Million, 2021 to 2034
3.2 Enteric Disease Testing Market Outlook by Type, $ Million, 2021 to 2034
3.3 Enteric Disease Testing Market Outlook by Product, $ Million, 2021 to 2034
3.4 Enteric Disease Testing Market Outlook by Application, $ Million, 2021 to 2034
3.5 Enteric Disease Testing Market Outlook by Key Countries, $ Million, 2021 to 2034
4 Market Dynamics
4.1 Key Driving Forces of Enteric Disease Testing Market Industry
4.2 Key Market Trends in Enteric Disease Testing Market Industry
4.3 Potential Opportunities in Enteric Disease Testing Market Industry
4.4 Key Challenges in Enteric Disease Testing Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Enteric Disease Testing Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Enteric Disease Testing Market Outlook By Segments
7.1 Enteric Disease Testing Market Outlook by Segments
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
8 North America Enteric Disease Testing Market Analysis And Outlook To 2034
8.1 Introduction to North America Enteric Disease Testing Markets in 2024
8.2 North America Enteric Disease Testing Market Size Outlook by Country, 2021-2034
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Enteric Disease Testing Market size Outlook by Segments, 2021-2034
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
9 Europe Enteric Disease Testing Market Analysis And Outlook To 2034
9.1 Introduction to Europe Enteric Disease Testing Markets in 2024
9.2 Europe Enteric Disease Testing Market Size Outlook by Country, 2021-2034
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Enteric Disease Testing Market Size Outlook By Segments, 2021-2034
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
10 Asia Pacific Enteric Disease Testing Market Analysis And Outlook To 2034
10.1 Introduction to Asia Pacific Enteric Disease Testing Markets in 2024
10.2 Asia Pacific Enteric Disease Testing Market Size Outlook by Country, 2021-2034
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Enteric Disease Testing Market size Outlook by Segments, 2021-2034
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
11 South America Enteric Disease Testing Market Analysis And Outlook To 2034
11.1 Introduction to South America Enteric Disease Testing Markets in 2024
11.2 South America Enteric Disease Testing Market Size Outlook by Country, 2021-2034
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Enteric Disease Testing Market size Outlook by Segments, 2021-2034
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
12 Middle East And Africa Enteric Disease Testing Market Analysis And Outlook To 2034
12.1 Introduction to Middle East and Africa Enteric Disease Testing Markets in 2024
12.2 Middle East and Africa Enteric Disease Testing Market Size Outlook by Country, 2021-2034
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Enteric Disease Testing Market size Outlook by Segments, 2021-2034
By Product
Reagents and Consumables
Equipment
By Technique
Molecular Diagnostics
Immunodiagnostics
By Disease Type
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
By End-User
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Becton, Dickinson and Company
Biomerica
BIOMÉRIEUX
Bio-Rad Laboratories Inc
Cepheid
Coris BioConcept
DiaSorin S.p.A.
Meridian Bioscience
Quest Diagnostics Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
By Technique
By Disease Type
By End-User
Geographical Analysis
The Global Enteric Disease Testing Market Size is estimated at $4.3 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 3.2% to reach $5.7 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott, Becton, Dickinson and Company, Biomerica, BIOMÉRIEUX, Bio-Rad Laboratories Inc, Cepheid, Coris BioConcept, DiaSorin S.p.A., Meridian Bioscience, Quest Diagnostics Inc
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume